Kent R. Olson

5.2k total citations
117 papers, 3.2k citations indexed

About

Kent R. Olson is a scholar working on Emergency Medicine, Pharmacology and Toxicology. According to data from OpenAlex, Kent R. Olson has authored 117 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Emergency Medicine, 22 papers in Pharmacology and 18 papers in Toxicology. Recurrent topics in Kent R. Olson's work include Poisoning and overdose treatments (67 papers), Drug-Induced Hepatotoxicity and Protection (19 papers) and Forensic Toxicology and Drug Analysis (18 papers). Kent R. Olson is often cited by papers focused on Poisoning and overdose treatments (67 papers), Drug-Induced Hepatotoxicity and Protection (19 papers) and Forensic Toxicology and Drug Analysis (18 papers). Kent R. Olson collaborates with scholars based in United States, Singapore and Taiwan. Kent R. Olson's co-authors include Thomas E. Kearney, Neal L. Benowitz, Paul D. Blanc, Susan M. Pond, Elizabeth J. Scharman, Peter A. Chyka, Alan D. Woolf, E. Martin Caravati, Anthony S. Manoguerra and Lisa L. Booze and has published in prestigious journals such as Journal of the American Chemical Society, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Kent R. Olson

115 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kent R. Olson United States 35 1.6k 673 460 435 390 117 3.2k
Edward P. Krenzelok United States 33 2.1k 1.3× 851 1.3× 345 0.8× 438 1.0× 417 1.1× 207 4.1k
James B. Mowry United States 22 2.0k 1.2× 558 0.8× 439 1.0× 405 0.9× 229 0.6× 42 3.6k
Louis R. Cantilena United States 30 1.6k 1.0× 913 1.4× 372 0.8× 614 1.4× 247 0.6× 69 6.0k
Jessica Youniss United States 8 1.9k 1.2× 414 0.6× 202 0.4× 293 0.7× 226 0.6× 9 2.7k
Paul M. Wax United States 31 1.3k 0.8× 415 0.6× 662 1.4× 443 1.0× 201 0.5× 123 3.1k
Henry A. Spiller United States 38 1.7k 1.0× 451 0.7× 783 1.7× 555 1.3× 524 1.3× 180 4.8k
E. Martin Caravati United States 32 1.3k 0.8× 391 0.6× 193 0.4× 284 0.7× 262 0.7× 74 2.6k
D. Nicholas Bateman United Kingdom 42 1.8k 1.1× 1.9k 2.8× 375 0.8× 513 1.2× 630 1.6× 257 6.5k
Alvin C. Bronstein United States 28 2.0k 1.3× 674 1.0× 583 1.3× 910 2.1× 194 0.5× 63 4.3k
Simon H. L. Thomas United Kingdom 33 847 0.5× 702 1.0× 644 1.4× 452 1.0× 243 0.6× 134 3.8k

Countries citing papers authored by Kent R. Olson

Since Specialization
Citations

This map shows the geographic impact of Kent R. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kent R. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kent R. Olson more than expected).

Fields of papers citing papers by Kent R. Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kent R. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kent R. Olson. The network helps show where Kent R. Olson may publish in the future.

Co-authorship network of co-authors of Kent R. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Kent R. Olson. A scholar is included among the top collaborators of Kent R. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kent R. Olson. Kent R. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sawe, Hendry R., Juma A. Mfinanga, John C. Stein, et al.. (2017). Patients with acute poisoning presenting to an urban emergency department of a tertiary hospital in Tanzania. BMC Research Notes. 10(1). 482–482. 19 indexed citations
2.
Chen, Hsien‐Yi, et al.. (2016). Clenbuterol causing non–ST-segment elevation myocardial infarction in a teenage female desiring to lose weight: case and brief literature review. The American Journal of Emergency Medicine. 34(8). 1739.e5–1739.e7. 11 indexed citations
3.
Richards, John R., Timothy E. Albertson, Robert W. Derlet, et al.. (2015). Treatment of toxicity from amphetamines, related derivatives, and analogues: A systematic clinical review. Drug and Alcohol Dependence. 150. 1–13. 62 indexed citations
4.
Gugelmann, Hallam, et al.. (2014). ‘Crazy Monkey’ Poisons Man and Dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid. Clinical Toxicology. 52(6). 635–638. 50 indexed citations
5.
Anderson, Ilene B., et al.. (2014). Massive Naproxen Overdose with Serial Serum Levels. Journal of Medical Toxicology. 11(1). 102–105. 11 indexed citations
6.
French, Deborah, Patil Armenian, Weiming Ruan, et al.. (2011). Serum verapamil concentrations before and after Intralipid® therapy during treatment of an overdose. Clinical Toxicology. 49(4). 340–344. 59 indexed citations
7.
Haller, Christine, et al.. (2008). Dietary supplement adverse events: Report of a one-year poison center surveillance project. Journal of Medical Toxicology. 4(2). 84–92. 65 indexed citations
8.
Olson, Kent R., et al.. (2008). Case files of the medical toxicology fellowship of the California poison control system—San Francisco: Calcium plus digoxin—More taboo than toxic?. Journal of Medical Toxicology. 4(1). 33–39. 7 indexed citations
9.
Thundiyil, Josef G., Thomas E. Kearney, & Kent R. Olson. (2007). Evolving epidemiology of drug-induced seizures reported to a poison control center system. Journal of Medical Toxicology. 3(1). 15–19. 92 indexed citations
10.
Kearney, Thomas E., et al.. (2006). Protocols for Pediatric Poisonings from Nontoxic Substances. Pediatric Emergency Care. 22(4). 215–221. 1 indexed citations
11.
Patel, Manish M., et al.. (2005). Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. Journal of Emergency Medicine. 29(4). 451–454. 30 indexed citations
12.
Miller, Michael A., et al.. (2003). Superwarfarin and Glass Ingestion with Prolonged Coagulopathy Requiring High‐Dose Vitamin K 1 Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(9). 1186–1189. 21 indexed citations
13.
Patel, Manish M., et al.. (2002). ED utilization of computed tomography in a poisoned population. The American Journal of Emergency Medicine. 20(3). 212–217. 13 indexed citations
14.
Phillips, Kathryn A., Rick Homan, Harold S. Luft, et al.. (1998). The Costs and Outcomes of Restricting Public Access to Poison Control Centers. Medical Care. 36(3). 271–280. 36 indexed citations
15.
Kearney, Thomas E., et al.. (1995). Health care cost effects of public use of a regional poison control center.. PubMed. 162(6). 499–504. 37 indexed citations
16.
D’Alessandro, A., et al.. (1994). Osmolar gap with Minimal Acidosis in Combined Methanol and Methyl Ethyl Ketone Ingestion. Journal of Toxicology Clinical Toxicology. 32(1). 79–84. 3 indexed citations
17.
Blanc, Paul D., Matthew Jones, & Kent R. Olson. (1993). Surveillance of poisoning and drug overdose through hospital discharge coding, poison control center reporting, and the Drug Abuse Warning Network. The American Journal of Emergency Medicine. 11(1). 14–19. 43 indexed citations
18.
Walter, Frank G., et al.. (1991). Acetaldehyde analysis in severe metaldehyde poisoning. 33(4). 374. 4 indexed citations
19.
Blanc, Paul D., et al.. (1990). Occupational illness and poison control centers. Referral patterns and service needs.. PubMed. 152(2). 181–4. 6 indexed citations
20.
Blanc, Paul D., et al.. (1990). Morbidity from inhalational exposures. 32(4). 362. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026